Epidemiology of erectili disfunction in Brazil: Results from a national research "Avaliar Project";Epidemiologia da disfunção erétil no Brasil: Resultados da pesquisa nacional do "Projeto Avaliar"

Revista Brasileira de Medicina

Volumn 61, Issue 9, 2004, Pages 613-619

  Duarte Moreira Jr , Edson ^a,b,f   Najjar Abdo, Carmita Helena ^c   Dos Santos, Djanilson Barbosa ^a   Wroclawski, Eric ^d   Saraiva Fittipaldi, João Antônio ^e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Sociedade Brasileira de Urologia

^e PFIZER INC   (United States)

^f NONE   (Brazil)

Author keywords

Brazil; Erectile dysfunction; Impotence; Prevalence; Risk factors

Indexed keywords

ADULT; ARTICLE; BRAZIL; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EDUCATION; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; ETHNIC DIFFERENCE; EXPERIENCE; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PROSTATE HYPERTROPHY; RACE DIFFERENCE; RESEARCH SUBJECT; SELF CONCEPT; SITTING; SOCIOECONOMICS;

EID: 7744241527     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. Jama 1993; 270:83-90.
2. Hauri D. Erectile dysfunction in the elderly man. Urol Int 2003; 70:89-99.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published erratum appears in JAMA 1999 Apr 7;281(13):1174] [see comments]. Jama 1999; 281:537-44.
4. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published erratum appears in JAMA 1999 Apr 7;281(13):1174] [see comments]. Jama 1999; 281:537-44.
5. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5-11.
6. Monga M, Rajasekaran M. Erectile dysfunction: current concepts and future directions. Arch Androl 2003; 49:7-17.
7. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction [see comments]. Br J Urol 1996; 78:257-61.
8. Morales A, Heaton JP, Johnston B, Adams M. Oral and topical treatment of erectile dysfunction. Present and future. Urol Clin North Am 1995; 22:879-86.
9. Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol 2003; 169:1999-2007.
10. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol 2003; 44:245-53.
11. Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol 2003; 169:1437-42.
12. Moreira ED, Jr., Abdo CH, Torres EB, Lobo CF, Fittipaldi JA. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001; 58:583-8.
13. Moreira ED, Jr., Bestane WJ, Bartolo EB, Fittipaldi JA. Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil. Sao Paulo Med J 2002; 120:49-54.
14. Moreira ED, Jr., Lisboa Lobo CF, Villa M, Nicolosi A, Glasser DB. Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: a population-based study. Int J Impot Res 2002; 14 Suppl 2:S3-9.
15. Moreira ED, Jr., Lbo CF, Diament A, Nicolosi A, Glasser DB. Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil. Urology 2003; 61:431-6.
16. Abdo CHN, Moreira ED, Santos DB, Wroclawski E, Fittipaldi JAS. Percepções e atitudes sobre disfunçã erétil entre médicos no Brasil: resultados do "Projeto Avaliar". Rev Bras Med 2004.
17. Abdo CHN, Moreira ED, RE W, Fittipaldi JAS. Pesquisa Nacional sobre saúde, hábitos de vida, disfunção sexual e respectiva conduta médica - "Projeto Avaliar". Rev Bras Med 2003; 60:53-60.
18. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. J Clin Epidemiol 1994; 47:457-67.
19. Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study [In Process Citation]. Int J Impot Res 2000; 12:197-204.
20. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirk-Patrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
21. O'Leary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology [see comments]. Urology 1995; 46:697-706.
22. IBGE IBdGeE. Anuário Estatístico do Brasil - 2000. Vol. 56. Rio de Janeiro, 2001.
23. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
24. Laumann EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res 1999; 11 Suppl 1:360-4.
25. Nicolosi A, Moreira ED, Jr., Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61:201-6.
26. Lyngdorf P, Hemmingsen L. Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. Int J Impot Res 2004.
27. Shiri R, Koskimaki J, Hakama M, et al. Prevalence and severity of erectile dysfunction in 50 to 75-year-old Finnish men. J Urol 2003; 170:2342-4.
28. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42:382-9.
29. Araujo AB, Johannes CB, Feldman HA, Derby CA, McKinlay JB. Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2000; 152:533-1.
30. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study [see comments]. J Urol 2000; 163:460-3.
31. Fedele D, Bortolotti A, Coscelli C, et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 2000; 29:524-31.
32. Cummings MH, Alexander WD. Erectile dysfunction in patients with diabetes. Hosp Med 1999; 60:638-44.
33. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20:323-34.
34. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003; 64 Suppl 10:5-10.
35. Roose SP. Depression: links with ischemie heart disease and erectile dysfunction. J Clin Psychiatry 2003; 64 Suppl 10:26-30.
36. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 2000; 86:41F-45F.
37. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52:848-52.
38. Khan MA, Morgan RJ, Mikhailidis DP. Sexual dysfunction in men with lower urinary tract symptoms and benign prostatic hyperplasia: an emerging link. BJU Int 2003; 92:822-3.
39. Quinn MJ. Benign prostatic hyperplasia and sexual dysfunction. Lancer 2003; 361:1562.
40. Boyle P, Robertson C, Mazzetta C, et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 2003; 92:719-25.
41. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30:328-38.
42. Sasayama S, Ishii N, Ishikura F, et al. Men's Health Study: epidemiology of erectile dysfunction and cardiovascular disease. Circ J 2003; 67:656-9.
43. Roumeguere T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003; 44:355-9.
44. Kolodny L. Erectile dysfunction and vascular disease. What is the connection? Postgrad Med 2003; 114:30-4, 39-40.
45. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56:302-6.
46. Mirone V, Imbimbo C, Bortolotti A, et al. Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 2002; 41:294-7.
47. Spangler JG, Summerson JH, Bell R, Konen JC. Cigarette smoking and erectile dysfunction. J Fam Pract 2002; 51:81.
48. Nicolosi A, Glasser DB, Moreira ED, Villa M, Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15:253-7.